Home
Platform
Services
Brands
Locations
Careers
News
Library
Responsibility
Contact Us
Platform
Our Platform
Our Competitive Edge
Services
Preclinical Development
Clinical Development
Regulatory Affairs & Consulting
Data Sciences
Molecular Laboratory R&D Services
Microbiology and Diagnostics R&D Services
Brands
Clinglobal
About us
Our Services
Our Team
Clinvet
About us
Our Services
Our Team
Clindata
About us
Our Services
Our Team
Clinomics
About us
Our Services
Our Team
Clinaxel
Rtilab
Locations
Careers
News
Social Media
Library
Research Models
Publications
Responsibility
Our Purpose
Our Values
Corporate Responsibility
Compliance
Contact us
A novel combination of fripronil and permethrin (Frontline Tri-Act, Frontect) reduces risk of transimission of B. canis by D. reticulatus and of E. canis by R. sanguineus
Home
A novel combination of fripronil and permethrin (Frontline Tri-Act, Frontect) reduces risk of transimission of B. canis by D. reticulatus and of E. canis by R. sanguineus
digitalplatforms
April 23, 2025
0 Comments
File Type:
pdf
File Size:
419 KB
Categories:
Publications
Post navigation
Previous
A comparative laboratory trial evaluating the immediate efficacy of fluralaner, afoxolaner, sarolaner and imidacloprid + permethrin against adult Rhipicephalus sanguineus (sensu lato) ticks attached to dogs
Next
A single oral dose of fluralaner (Bravecto®) in dogs rapidly kills 100% of blood-fed Phlebotomus perniciosus, a main visceral le
